How do I buy CRISPR Therapeutics (CRSP) stock?

You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.View our list of the best stock brokerages

Who are CRISPR Therapeutics (CRSP) competitors?

Other companies in CRISPR Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Legend Biotech Corp (NASDAQ:LEGN), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC) and Alkermes PLC (NASDAQ:ALKS).

What is the forecast, or price target, for CRISPR Therapeutics (CRSP) stock?

CRISPR Therapeutics has a consensus price target of $72.17.

What is the current price for CRISPR Therapeutics (CRSP)?

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $55.15 last updated January 22, 2026 at 6:53 AM EST.

Does CRISPR Therapeutics (CRSP) pay a dividend?

There are no upcoming dividends for CRISPR Therapeutics.

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

CRISPR Therapeutics does not have any upcoming earnings scheduled.

Is CRISPR Therapeutics (CRSP) going to split?

There is no upcoming split for CRISPR Therapeutics.

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

CRISPR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRISPR Therapeutics (CRSP) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

Comments